San Diego-based mostly Viking Therapeutics marked alone as a significant competitor inside the weight loss drug marketplace in February immediately after revealing promising information from a mid-phase demo of experimental drug VK2735, which instructed it rivaled—and outperformed—Novo and Lilly drugs when given as a weekly injection and in Mar… Read More